Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1

Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma

(2012) Hyun Joo Jung et al.   AMERICAN JOURNAL OF HEMATOLOGY

Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study

(2011) W.-Y. Au et al.   BLOOD

From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia

(2011) S.-J. Chen et al.   BLOOD

Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era

(2010) P. Perez-Galan et al.   BLOOD

Arsenic Trioxide Controls the Fate of the PML-RAR  Oncoprotein by Directly Binding PML

(2010) X. W. Zhang et al.   SCIENCE

How I treat acute promyelocytic leukemia

(2009) M. S. Tallman et al.   BLOOD

Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy

(2008) W.-Y. Au et al.   BLOOD

Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study

(2008) JE Chang et al.   HEMATOLOGICAL ONCOLOGY